SLC6A3 and Alzheimer disease: High gut levels of DAT have been already associated to immune-regulatory functions [35], while Wang and colleagues demonstrated that 3-3-hydroxyphenylpropanoic acid might interfere with the assembly of β-amyloid (Aβ) peptides into neurotoxic Aβ aggregates and could play key roles in AD pathogenesis [36].